Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2 study of YL-13027 in combination with sintilimab in patients with advanced solid tumors is ongoing (Phase 1 and Phase 2).
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
This Phase 1 study evaluated pevonedistat in combination with irinotecan and temozolomide in patients with recurrent or refractory solid tum…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating Telaglenastat (CB-839) with Palbociclib in solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: 6MW3511 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]
Clinical trial update for 6MW3511 in advanced solid tumors across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update investigates combination of duvelisib with SG001 injection in patients with advanced solid tumors (Phase 1/Phase 2).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Evixapodlin (formerly GS-4224) in participants with advanced solid tumors was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0) [Phase 2]
Phase 2 trial investigating hypofractionated radiotherapy with a PD-1 inhibitor followed by GM-CSF and IL-2 for advanced refractory solid tu…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor [Phase 2]
A Phase 2 clinical trial update for avelumab in biomarker-driven advanced solid tumors, including PD-L1 positive, EBV-positive, MSI-H, and P…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers [Phase 2]
Phase 2 trial update evaluating SHR-A1811 in combination with Fluzoparib for HER2-expressing cancers (advanced solid tumors).
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Navarixin in combination with pembrolizumab in adults with selected advanced/metastatic …
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for MAX-40279 combined with KN046 in advanced/metastatic solid tumors (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for ARRY-382 in combination with pembrolizumab in advanced solid tumors; the study (Phase 1/2) has been terminated wit…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors [Phase 4]
A Phase 4 trial assessing the safety and efficacy of sirolimus in subjects with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]
Clinical trial update for 9MW2821 in advanced malignant solid tumors across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001) [Phase 1]
Phase 1 trial of Vevorisertib (ARQ 751) as a single agent or with other anti-cancer agents in solid tumors with PIK3CA/AKT/PTEN mutations; t…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors [Phase 4]
Phase 4 trial evaluating the safety and efficacy of sunitinib in patients with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-06Clinical Trial Update: A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of CS1001 in combination with regorafenib for advanced or refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating chidamide, decitabine, and immune checkpoint inhibitors in relapsed/refractory non-Hodgkin lymphoma an…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial updates safety and pharmacokinetics of cobimetinib in pediatric and young adult patients with previously treated solid tumor…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: M8891 First in Human in Solid Tumors [Phase 1]
Phase 1 first-in-human trial of M8891 in solid tumors has been terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of SRA737 in advanced solid tumors and non-Hodgkin's lymphoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-28Clinical Trial Update: Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002) [Phase 1]
Phase 1 trial of intratumoral/intralesional MK-4621/JetPEI with or without pembrolizumab in advanced/metastatic or recurrent solid tumors; s…
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial update for docetaxel polymeric micelles for injection in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. [Phase 1, Phase 2]
Phase 1/2 trial evaluating LAG525 as a single agent and in combination with PDR001 in patients with advanced solid tumors; results have been…